
Boston Globe
<img alt="" height="1" width="1" />
Astra Slides as Drug Falls Short of Rival
Wall Street Journal
LONDON—AstraZeneca PLC's anticholesterol medicine Crestor failed to beat its top rival, Pfizer Inc.'s Lipitor, in a key clinical trial, hurting chances the British company's top drug can boost its sales when the world's best-selling ...
AstraZeneca Shares Fall on Crestor Study ResultBloomberg
Astra's Crestor drug fails to beat Pfizer's LipitorReuters
AstraZeneca Says Crestor Failed To Reach 'statistical Significance' Over LipitorRTT News
The Associated Press -BusinessWeek -Pharmaceutical Business Review
all 216 news articles »
More...